Phase II studies of BEZ235 in patients with advanced pancreatic neuroendocrine tumors (pNET).
暂无分享，去创建一个
S. Libutti | R. Salazar | E. Baudin | L. Antonuzzo | James C Yao | C. Verslype | N. Fazio | R. García-Carbonero | R. Hubner | N. Mukherjee | E. Wolin | P. Aimone | R. Buzzoni | A. Custodio | Fabian Herbst | S. Turri | D. Dey | Joseph Sulovski | J. Yao